由BMP2/4-ACVR1信号介导的前瘤巨细胞极化在瘤发作过程中调节一个免疫抑制的微环境
Mingchao Wang1, Zhihong Song1, Hao Yuan1
1Tsinghua University, Beijing, China.
Cancer research
|November 17, 2025
概括
这项研究揭示了亲瘤巨细胞如何在肺癌中创造"冷"瘤微环境 (cTME). 准ACVR1将cTME转化为"热"的,抑制瘤生长并提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 癌细胞通过创造一种免疫抑制的"冷"瘤微环境 (cTME) 来逃避免疫监测.
- 了解cTME形成对于开发有效的免疫疗法至关重要.
- 由EGFR驱动的肺腺癌 (LUAD) 是癌症研究的一个重要领域.
研究的目的:
- 调查EGFR驱动的LUAD早期阶段cTME形成的时间动态.
- 确定推动cTME建立的关键细胞和分子机制.
- 探索将cTME转化为"热"TME (hTME) 的潜在治疗点.
主要方法:
- 单细胞RNA测序用于分析EGFR驱动LUAD的小鼠模型中的瘤发育阶段.
- 巨细胞极化动态从抗瘤到亲瘤的表型被追踪.
- 研究了BMP2/4-ACVR1信号轴在cTME形成中的作用.
- 测试了ACVR1抑制作为一种扭转cTME特征的策略.
主要成果:
- 大细胞从抗瘤状态转移到亲瘤状态,指挥着cTME的形成.
- 来自瘤的BMP2/4信号诱导了前瘤巨细胞两极分化.
- 通过ACVR1抑制剂抑制BMP2/4-ACVR1轴将cTME转化为hTME,抑制瘤生长.
- EGFR突变LUAD患者表现出类似的cTME特征,高ACVR1表达与预后不佳相关.
结论:
- 前瘤巨细胞在EGFR突变LUAD中cTME的初始发展中发挥着关键作用.
- 针对BMP2/4-ACVR1轴,特别是ACVR1,是一个有前途的治疗策略.
- 这种方法可以将cTME转化为hTME,从而导致EGFR突变肺癌中强大的瘤生长抑制.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K


